Integrated Research shares on watch following major contract renewal

The Integrated Research Limited (ASX: IRI) share price will be on watch for the remainder of the day after announcing a contract renewal.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Integrated Research Limited (ASX: IRI) share price will be on watch for the remainder of the day after the company announced the renewal and extension of a major client software agreement.

At the time of writing, Integrated Research shares were down by 1.8% on a day which has seen the S&P/ASX 200 Index (ASX: XJO) fall sharply so far by 3.2%.

Integrated Research is a provider of performance management software for critical IT infrastructure, payments and unified communications.

Over the past 12 months, the Integrated Research share price has risen by 12% and while the ASX 200 Index has lost over 20% in the current crash, Integrated Research has been much less impacted, falling by only 6%.

a woman

Details of contract renewal with JP Morgan Chase

At around midday today, Integrated Research announced it has renewed and extended its software license agreement with JP Morgan Chase for a very sizeable total contract value of US$10 million. The tech provider added that the contract has been extended for a 5-year term and the terms of the contract encompass products in Integrated Research's Payments and Infrastructure portfolio.

For the past 25 years, JP Morgan Chase has been using Integrated Research's IR Prognosis solution in order to tap into real-time payment transaction data to support its core business decisions.

Integrated Research commented that one of the key reasons behind JP Morgan's decision to renew were the recent innovations and enhancements that Integrated Research made to its current 11.7 version IR Prognosis product.

Commenting on today's announcement, John Ruthven, Chief Executive Officer of Integrated Research said, "This contract is further validation of the mission critical nature of IR solutions with major enterprises."

Recap of recent financial result announcement

As announced last month, Integrated Research achieved a 1% increase in profit after tax to $11.8 million for its H1 FY2020 results, when compared to the prior corresponding period. Meanwhile, overall license sales increased by 7% to $33.4 million and total revenue increased by 6% to $53.2 million. However, its payments revenue declined by 14% to $7.8 million.

The company declared a fully franked interim dividend of 3.5 cents per share and noted that it has maintained a strong financial position with total cash of $7.6 million at 31 December 2019.

Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Integrated Research Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

a couple consider the advice from a man with documents laid out on a table and the man holding a tablet in his hand.
Financial Shares

3 ASX 200 financial shares to sell: experts

ASX 200 financial shares are down 2.5% over six months and up 2.1% in 2026-to-date.

Read more »

A man rests his chin in his hands, pondering what is the answer?
Broker Notes

What is Morgans saying about Cochlear and Northern Star shares?

Here's what the broker is saying about these big names following their updates.

Read more »

A woman with a mobile phone in her hand looks sceptical with a puzzled expression on her face with an eyebrow raised and pursed lips.
Broker Notes

Buy, hold, sell: NextDC, Hub24, PLS Group shares

The market is pessimistic about the next round of talks between the US and Iran.

Read more »

A team of people giving the thumbs up sign.
Broker Notes

5 ASX 200 shares with renewed buy ratings this week

Brokers have indicated continuing confidence in Cochlear, REA, and several other ASX 200 shares.

Read more »

a man sits at his desk wearing a business shirt and tie and has a hearty laugh at something on his mobile phone.
Share Gainers

Why Deep Yellow, Develop Global, Resolute Mining, and Santos shares are pushing higher today

These shares are catching the eye on Thursday. But why?

Read more »

An arrow crashes through the ground as a businessman watches on.
Healthcare Shares

Cochlear stock down 40%: How much has this cost ASX investors?

One day can ruin years of success...

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why Black Cat, Mirvac, Qantas, and Temple & Webster shares are falling today

These shares are having a tough session. But why?

Read more »

An old-fashioned news boy stands on a stool and yells through a microphone in an open field.
Share Market News

Why is everyone talking about Core Lithium, Ampol and Santos shares on Thursday?

Ampol, Core Lithium and Santos shares are making waves on Thursday. But why?

Read more »